Retrobulbar dexmedetomidine in pediatric vitreoretinal surgery eliminates the need for intraoperative fentanyl and postoperative analgesia: A randomized controlled study

Purpose: This study evaluated the efficacy of retrobulbar ropivacaine plus dexmedetomidine compared with systemic fentanyl in pediatric vitreoretinal (VR) surgery. Methods: This prospective double-blind, randomized controlled study was performed in 60 children undergoing VR surgery, age from 2 to 7...

Full description

Bibliographic Details
Main Authors: Weidi Ye, Yuhan Hu, Yuntao Wu, Zhirui Zhu, Xiuming Jin, Zhiyong Hu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2019;volume=67;issue=6;spage=922;epage=927;aulast=Ye
_version_ 1818062722516910080
author Weidi Ye
Yuhan Hu
Yuntao Wu
Zhirui Zhu
Xiuming Jin
Zhiyong Hu
author_facet Weidi Ye
Yuhan Hu
Yuntao Wu
Zhirui Zhu
Xiuming Jin
Zhiyong Hu
author_sort Weidi Ye
collection DOAJ
description Purpose: This study evaluated the efficacy of retrobulbar ropivacaine plus dexmedetomidine compared with systemic fentanyl in pediatric vitreoretinal (VR) surgery. Methods: This prospective double-blind, randomized controlled study was performed in 60 children undergoing VR surgery, age from 2 to 7 years. After general anesthesia, the following procedure was administrated: (1) retrobulbar block with 0.5% ropivacaine plus dexmedetomidine 1 μg/kg (group RD, n = 20), (2) retrobulbar block with 0.5% ropivacaine (group RB, n = 20), and (3) control group with general anesthesia only (group F, n = 20). Hemodynamics, postoperative pain scores, anesthetics consumption (remifentanil, propofol, fentanyl), and emergence agitation were recorded. Results: Respiratory depression was observed in 7 of the 20 patients in group F after the laryngeal mask airway was removed in the operating room, compared with none in groups RD and RB. All patients in group F required intraoperative rescue fentanyl (average intraoperative fentanyl consumption, 26.6 ± 12.6 μg per patient). Some rescue fentanyl was required in group RB (three patients required one dose of rescue fentanyl). Patients in group RD required none. Groups RD and RB reported lower pain scores than group F at 4 h postoperatively (RD group: P < 0.001; RB group: P =0.002); pain scores in group RD were lower than that in group F at 6 h postoperatively (P < 0.001). Conclusion: Retrobulbar dexmedetomidine as an adjuvant to ropivacaine is a safe and effective alternative to systemic fentanyl. This regimen provides better pain management, hemodynamic stability, and stress response suppression in pediatric VR surgery.
first_indexed 2024-12-10T14:08:44Z
format Article
id doaj.art-663a5e7e7870437697e26d583bc40fd6
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-12-10T14:08:44Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-663a5e7e7870437697e26d583bc40fd62022-12-22T01:45:34ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892019-01-0167692292710.4103/ijo.IJO_1905_18Retrobulbar dexmedetomidine in pediatric vitreoretinal surgery eliminates the need for intraoperative fentanyl and postoperative analgesia: A randomized controlled studyWeidi YeYuhan HuYuntao WuZhirui ZhuXiuming JinZhiyong HuPurpose: This study evaluated the efficacy of retrobulbar ropivacaine plus dexmedetomidine compared with systemic fentanyl in pediatric vitreoretinal (VR) surgery. Methods: This prospective double-blind, randomized controlled study was performed in 60 children undergoing VR surgery, age from 2 to 7 years. After general anesthesia, the following procedure was administrated: (1) retrobulbar block with 0.5% ropivacaine plus dexmedetomidine 1 μg/kg (group RD, n = 20), (2) retrobulbar block with 0.5% ropivacaine (group RB, n = 20), and (3) control group with general anesthesia only (group F, n = 20). Hemodynamics, postoperative pain scores, anesthetics consumption (remifentanil, propofol, fentanyl), and emergence agitation were recorded. Results: Respiratory depression was observed in 7 of the 20 patients in group F after the laryngeal mask airway was removed in the operating room, compared with none in groups RD and RB. All patients in group F required intraoperative rescue fentanyl (average intraoperative fentanyl consumption, 26.6 ± 12.6 μg per patient). Some rescue fentanyl was required in group RB (three patients required one dose of rescue fentanyl). Patients in group RD required none. Groups RD and RB reported lower pain scores than group F at 4 h postoperatively (RD group: P < 0.001; RB group: P =0.002); pain scores in group RD were lower than that in group F at 6 h postoperatively (P < 0.001). Conclusion: Retrobulbar dexmedetomidine as an adjuvant to ropivacaine is a safe and effective alternative to systemic fentanyl. This regimen provides better pain management, hemodynamic stability, and stress response suppression in pediatric VR surgery.http://www.ijo.in/article.asp?issn=0301-4738;year=2019;volume=67;issue=6;spage=922;epage=927;aulast=YePediatricretrobulbar dexmedetomidineropivacainevitreoretinal surgery
spellingShingle Weidi Ye
Yuhan Hu
Yuntao Wu
Zhirui Zhu
Xiuming Jin
Zhiyong Hu
Retrobulbar dexmedetomidine in pediatric vitreoretinal surgery eliminates the need for intraoperative fentanyl and postoperative analgesia: A randomized controlled study
Indian Journal of Ophthalmology
Pediatric
retrobulbar dexmedetomidine
ropivacaine
vitreoretinal surgery
title Retrobulbar dexmedetomidine in pediatric vitreoretinal surgery eliminates the need for intraoperative fentanyl and postoperative analgesia: A randomized controlled study
title_full Retrobulbar dexmedetomidine in pediatric vitreoretinal surgery eliminates the need for intraoperative fentanyl and postoperative analgesia: A randomized controlled study
title_fullStr Retrobulbar dexmedetomidine in pediatric vitreoretinal surgery eliminates the need for intraoperative fentanyl and postoperative analgesia: A randomized controlled study
title_full_unstemmed Retrobulbar dexmedetomidine in pediatric vitreoretinal surgery eliminates the need for intraoperative fentanyl and postoperative analgesia: A randomized controlled study
title_short Retrobulbar dexmedetomidine in pediatric vitreoretinal surgery eliminates the need for intraoperative fentanyl and postoperative analgesia: A randomized controlled study
title_sort retrobulbar dexmedetomidine in pediatric vitreoretinal surgery eliminates the need for intraoperative fentanyl and postoperative analgesia a randomized controlled study
topic Pediatric
retrobulbar dexmedetomidine
ropivacaine
vitreoretinal surgery
url http://www.ijo.in/article.asp?issn=0301-4738;year=2019;volume=67;issue=6;spage=922;epage=927;aulast=Ye
work_keys_str_mv AT weidiye retrobulbardexmedetomidineinpediatricvitreoretinalsurgeryeliminatestheneedforintraoperativefentanylandpostoperativeanalgesiaarandomizedcontrolledstudy
AT yuhanhu retrobulbardexmedetomidineinpediatricvitreoretinalsurgeryeliminatestheneedforintraoperativefentanylandpostoperativeanalgesiaarandomizedcontrolledstudy
AT yuntaowu retrobulbardexmedetomidineinpediatricvitreoretinalsurgeryeliminatestheneedforintraoperativefentanylandpostoperativeanalgesiaarandomizedcontrolledstudy
AT zhiruizhu retrobulbardexmedetomidineinpediatricvitreoretinalsurgeryeliminatestheneedforintraoperativefentanylandpostoperativeanalgesiaarandomizedcontrolledstudy
AT xiumingjin retrobulbardexmedetomidineinpediatricvitreoretinalsurgeryeliminatestheneedforintraoperativefentanylandpostoperativeanalgesiaarandomizedcontrolledstudy
AT zhiyonghu retrobulbardexmedetomidineinpediatricvitreoretinalsurgeryeliminatestheneedforintraoperativefentanylandpostoperativeanalgesiaarandomizedcontrolledstudy